glucagon has been researched along with Bone Cancer in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deguchi, H; Ichinose, M; Iguchi, M; Inoue, I; Iso-O, N; Kato, J; Kawai, M; Maeda, H; Maekita, T; Moribata, K; Nakamura, Y; Oka, M; Shingaki, N; Shirai, K; Tamai, H; Ueda, K; Yamaue, H; Yanaoka, K; Yasuoka, H | 1 |
Arafah, B; Manni, A; Pearson, OH | 1 |
al-Sheibani, S; Knapp, ML; Riches, PG | 1 |
1 trial(s) available for glucagon and Bone Cancer
Article | Year |
---|---|
Trioxifene mesylate (LY 133314): a new antiestrogen which inhibits growth hormone secretion in the rat.
Topics: Aged; Animals; Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Estrogen Antagonists; Female; Glucagon; Gonadotropins, Pituitary; Growth Hormone; Humans; Middle Aged; Pyrrolidines; Rats | 1980 |
2 other study(ies) available for glucagon and Bone Cancer
Article | Year |
---|---|
A case of a giant glucagonoma with parathyroid hormone-related peptide secretion showing an inconsistent postsurgical endocrine status.
Topics: Bone Neoplasms; Female; Glucagon; Glucagonoma; Humans; Liver Neoplasms; Middle Aged; Pancreatic Neoplasms; Parathyroid Hormone-Related Protein; Postoperative Period | 2011 |
Alterations of serum lipids in breast cancer: effects of disease activity, treatment, and hormonal factors.
Topics: Alcohol Drinking; Bone Neoplasms; Breast Neoplasms; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Fasting; Female; Glucagon; Hormones; Humans; Lipids; Smoking; Triglycerides; Tumor Necrosis Factor-alpha; Weight Loss | 1991 |